Educational Intervention to Increase Select Guideline-recommended Cardioprotective Medications in Patients With Diabetes

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This is an educational outreach to patients with type 2 diabetes mellitus (T2DM) and atherosclerotic cardiovascular disease (ASCVD) and their primary care and specialist providers to improve use of guideline-recommended treatments, specifically sodium-glucose cotransporter 2 inhibitor (SGLT2i) and glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications.
Epistemonikos ID: d9fdc7c21bc7ed24c0f2d4e9f1ffd6efc1e3794e
First added on: May 08, 2024